Natural and vaccine-induced antibody and cellular responses against emerging SARS-CoV-2 variants of concern (2021)
Attributed to:
Phase 1 COVID-19 Immunity - National Core Study
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.21203/rs.3.rs-224655/v1
Publication URI: http://dx.doi.org/10.21203/rs.3.rs-224655/v1
Type: Preprint